U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) - 11/16/2021
  1. News & Events for Human Drugs

Public | Virtual

Event Title
Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA)
November 16, 2021

Date:
November 16, 2021

FDA is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments for fiscal years 2023 through 2027.  The virtual public meeting will be held on November 16, 2021, from 9 a.m. to 2 p.m. ET. The meeting agenda, public docket information, additional materials, and any other updates will also be posted to this website as they become available.   
 
You can register for the meeting here​. Registration is not required to view the meeting, however, registrants will receive email updates and notices when new information becomes available. If you wish to present during a public comment session, please submit your request to GenericDrugPolicy@fda.hhs.gov by 11:59 p.m. ET on November 8, 2021. 

Date: November 16, 2021 

Time: 9:00 AM - 2:00 PM ET 

Webinar Information: 
Zoom meeting link

Webinar Meeting ID: 
160 003 0426 

Webinar Password (Case-Sensitive): 
GDUFa3!

Federal Register Notice

Event Materials

Back to Top